{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:29:55Z","timestamp":1762432195814,"version":"3.37.3"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15GRNT22420001"],"award-info":[{"award-number":["15GRNT22420001"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The George Link Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11695-022-06053-5","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T03:46:42Z","timestamp":1649908002000},"page":"2010-2022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reversal of NAFLD After VSG Is Independent of Weight-Loss but RYGB Offers More Efficacy When Maintained on a High-Fat Diet"],"prefix":"10.1007","volume":"32","author":[{"given":"Ankita","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Palaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaohui Lisa","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collin","family":"Brathwaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-5159","authenticated-orcid":false,"given":"Louis","family":"Ragolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"issue":"1","key":"6053_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"6053_CR2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"8","key":"6053_CR3","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348.","journal-title":"Metabolism"},{"doi-asserted-by":"crossref","unstructured":"Lee Y, et al. Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: A systematic review and meta-analysis. Clin Gastroenterol Hepatol.\u00a02019;17(6):1040\u20131060.e11.","key":"6053_CR4","DOI":"10.1016\/j.cgh.2018.10.017"},{"issue":"1","key":"6053_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1381\/096089204772787293","volume":"14","author":"S Shalhub","year":"2004","unstructured":"Shalhub S, et al. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg. 2004;14(1):54\u20139.","journal-title":"Obes Surg"},{"issue":"12","key":"6053_CR6","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1007\/s11695-015-1691-x","volume":"25","author":"G Bower","year":"2015","unstructured":"Bower G, et al. Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology. Obes Surg. 2015;25(12):2280\u20139.","journal-title":"Obes Surg"},{"issue":"12","key":"6053_CR7","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, et al. Nonalcoholic Steatohepatitis: A Review. JAMA. 2020;323(12):1175\u201383.","journal-title":"JAMA"},{"issue":"6","key":"6053_CR8","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2337\/db17-1028","volume":"67","author":"S Abu-Gazala","year":"2018","unstructured":"Abu-Gazala S, et al. Sleeve gastrectomy improves glycemia independent of weight loss by restoring hepatic insulin sensitivity. Diabetes. 2018;67(6):1079\u201385.","journal-title":"Diabetes"},{"issue":"7","key":"6053_CR9","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1007\/s11695-021-05389-8","volume":"31","author":"M Stevenson","year":"2021","unstructured":"Stevenson M, et al. RYGB Is More Effective than VSG at Protecting Mice from Prolonged High-Fat Diet Exposure: An Occasion to Roll Up Our Sleeves? Obes Surg. 2021;31(7):3227\u201341.","journal-title":"Obes Surg"},{"issue":"12","key":"6053_CR10","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1007\/s11695-019-04205-8","volume":"29","author":"M Stevenson","year":"2019","unstructured":"Stevenson M, et al. Surgical mouse models of vertical sleeve gastrectomy and Roux-en Y gastric bypass: a review. Obes Surg. 2019;29(12):4084\u201394.","journal-title":"Obes Surg"},{"issue":"6","key":"6053_CR11","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.bbadis.2019.04.006","volume":"1865","author":"X Zhang","year":"2019","unstructured":"Zhang X, et al. Dietary cholesterol is essential to mast cell activation and associated obesity and diabetes in mice. Biochim Biophys Acta Mol Basis Dis. 2019;1865(6):1690\u2013700.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"6053_CR12","doi-asserted-by":"publisher","first-page":"106585","DOI":"10.1016\/j.prostaglandins.2021.106585","volume":"157","author":"A Srivastava","year":"2021","unstructured":"Srivastava A, et al. Lipocalin-type prostaglandin D2 synthase appears to function as a novel adipokine preventing adipose dysfunction in response to a high fat diet. Prostaglandins Other Lipid Mediat. 2021;157:106585.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"3","key":"6053_CR13","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/cphy.c120023","volume":"3","author":"JY Chiang","year":"2013","unstructured":"Chiang JY. Bile acid metabolism and signaling. Compr Physiol. 2013;3(3):1191\u2013212.","journal-title":"Compr Physiol"},{"issue":"8","key":"6053_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas C, et al. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7(8):678\u201393.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"6053_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000450917","volume":"35","author":"M Reich","year":"2017","unstructured":"Reich M, et al. Role of the G protein-coupled bile acid receptor TGR5 in liver damage. Dig Dis. 2017;35(3):235\u201340.","journal-title":"Dig Dis"},{"issue":"4","key":"6053_CR16","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/hep.24525","volume":"54","author":"YD Wang","year":"2011","unstructured":"Wang YD, et al. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice. Hepatology. 2011;54(4):1421\u201332.","journal-title":"Hepatology"},{"key":"6053_CR17","doi-asserted-by":"publisher","first-page":"609060","DOI":"10.3389\/fimmu.2020.609060","volume":"11","author":"Y Shi","year":"2020","unstructured":"Shi Y, et al. TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome activation. Front Immunol. 2020;11:609060.","journal-title":"Front Immunol"},{"issue":"4","key":"6053_CR18","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3349\/ymj.2017.58.4.756","volume":"58","author":"BH Park","year":"2017","unstructured":"Park BH, et al. Pathologic impact of insulin resistance and sensitivity on the severity of liver histopathology in pediatric non-alcoholic steatohepatitis. Yonsei Med J. 2017;58(4):756\u201362.","journal-title":"Yonsei Med J"},{"issue":"9","key":"6053_CR19","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1530\/EC-19-0366","volume":"8","author":"F Van de Velde","year":"2019","unstructured":"Van de Velde F, et al. Insulin resistance associates with hepatic lobular inflammation in subjects with obesity. Endocr Connect. 2019;8(9):1294\u2013301.","journal-title":"Endocr Connect"},{"doi-asserted-by":"crossref","unstructured":"Taitano AA, et al. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg. 2015;19(3):429\u201336; discussion 436\u20137.","key":"6053_CR20","DOI":"10.1007\/s11605-014-2678-y"},{"issue":"2","key":"6053_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1053\/j.gastro.2009.04.052","volume":"137","author":"P Mathurin","year":"2009","unstructured":"Mathurin P, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137(2):532\u201340.","journal-title":"Gastroenterology"},{"issue":"6","key":"6053_CR22","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1053\/j.gastro.2006.01.042","volume":"130","author":"S Klein","year":"2006","unstructured":"Klein S, et al. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology. 2006;130(6):1564\u201372.","journal-title":"Gastroenterology"},{"issue":"6","key":"6053_CR23","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1007\/s11695-021-05412-y","volume":"31","author":"ESMB de Brito","year":"2021","unstructured":"de Brito ESMB, et al. Gastric bypass compared with sleeve gastrectomy for nonalcoholic fatty liver disease: a systematic review and meta-analysis. Obes Surg. 2021;31(6):2762\u201372.","journal-title":"Obes Surg"},{"issue":"5","key":"6053_CR24","doi-asserted-by":"publisher","first-page":"8713","DOI":"10.3390\/ijms15058713","volume":"15","author":"F Nassir","year":"2014","unstructured":"Nassir F, Ibdah JA. Role of mitochondria in nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(5):8713\u201342.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6053_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/gutjnl-2014-306748","volume":"64","author":"J Verbeek","year":"2015","unstructured":"Verbeek J, et al. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. Gut. 2015;64(4):673\u201383.","journal-title":"Gut"},{"issue":"2","key":"6053_CR26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2337\/dc17-0738","volume":"41","author":"H Immonen","year":"2018","unstructured":"Immonen H, et al. Increased liver fatty acid uptake is partly reversed and liver fat content normalized after bariatric surgery. Diabetes Care. 2018;41(2):368\u201371.","journal-title":"Diabetes Care"},{"doi-asserted-by":"crossref","unstructured":"Syed-Abdul MM, et al. Improvements in nonalcoholic fatty liver disease (NAFLD) after metabolic surgery is linked to an increased hepatic fatty acid oxidation\u2014a case report. 2021;2021. 1.","key":"6053_CR27","DOI":"10.21037\/asj-20-5"},{"key":"6053_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","volume":"136","author":"S Kersten","year":"2017","unstructured":"Kersten S, Stienstra R. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver. Biochimie. 2017;136:75\u201384.","journal-title":"Biochimie"},{"issue":"18","key":"6053_CR29","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75(18):3313\u201327.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"6053_CR30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/nu10060760","volume":"10","author":"MS Afonso","year":"2018","unstructured":"Afonso MS, et al. Molecular pathways underlying cholesterol homeostasis. Nutrients. 2018;10(6):760.","journal-title":"Nutrients."},{"issue":"4","key":"6053_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21(4):225\u201345.","journal-title":"Nat Rev Mol Cell Biol"},{"doi-asserted-by":"crossref","unstructured":"Lorkowski SW, et al. Bariatric surgery improves HDL function examined by ApoA1 exchange rate and cholesterol efflux capacity in patients with obesity and type 2 diabetes. Biomolecules. 2020;10(4):551.","key":"6053_CR32","DOI":"10.3390\/biom10040551"},{"issue":"1","key":"6053_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/ATVBAHA.117.310102","volume":"38","author":"SP Heffron","year":"2018","unstructured":"Heffron SP, et al. Changes in high-density lipoprotein cholesterol efflux capacity after bariatric surgery are procedure dependent. Arterioscler Thromb Vasc Biol. 2018;38(1):245\u201354.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"6053_CR34","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1210\/jc.2010-2378","volume":"96","author":"J Aron-Wisnewsky","year":"2011","unstructured":"Aron-Wisnewsky J, et al. Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women. J Clin Endocrinol Metab. 2011;96(4):1151\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6053_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s13105-014-0336-1","volume":"70","author":"P Quintero","year":"2014","unstructured":"Quintero P, et al. Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion. J Physiol Biochem. 2014;70(3):667\u201374.","journal-title":"J Physiol Biochem"},{"issue":"7","key":"6053_CR36","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s10620-014-3028-3","volume":"59","author":"X Jia","year":"2014","unstructured":"Jia X, et al. A possible role of chenodeoxycholic acid and glycine-conjugated bile acids in fibrotic steatohepatitis in a dietary rat model. Dig Dis Sci. 2014;59(7):1490\u2013501.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"6053_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.taap.2013.01.022","volume":"268","author":"AD Lake","year":"2013","unstructured":"Lake AD, et al. Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease. Toxicol Appl Pharmacol. 2013;268(2):132\u201340.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"9","key":"6053_CR38","doi-asserted-by":"publisher","first-page":"E1225","DOI":"10.1210\/jc.2015-2467","volume":"100","author":"VL Albaugh","year":"2015","unstructured":"Albaugh VL, et al. Early increases in bile acids post Roux-en-Y gastric bypass are driven by insulin-sensitizing, secondary bile acids. J Clin Endocrinol Metab. 2015;100(9):E1225\u201333.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"6053_CR39","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/ijo.2013.38","volume":"37","author":"NN Ahmad","year":"2013","unstructured":"Ahmad NN, Pfalzer A, Kaplan LM. Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes (Lond). 2013;37(12):1553\u20139.","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"6053_CR40","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.clnu.2014.09.018","volume":"34","author":"S De Giorgi","year":"2015","unstructured":"De Giorgi S, et al. Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: a cross-sectional pilot study. Clin Nutr. 2015;34(5):911\u20137.","journal-title":"Clin Nutr"},{"issue":"7","key":"6053_CR41","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2337\/dc12-2255","volume":"36","author":"GS Gerhard","year":"2013","unstructured":"Gerhard GS, et al. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass. Diabetes Care. 2013;36(7):1859\u201364.","journal-title":"Diabetes Care"},{"issue":"8","key":"6053_CR42","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1210\/en.2011-2145","volume":"153","author":"DJ Pournaras","year":"2012","unstructured":"Pournaras DJ, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology. 2012;153(8):3613\u20139.","journal-title":"Endocrinology"},{"issue":"9","key":"6053_CR43","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s11695-012-0673-5","volume":"22","author":"M Simonen","year":"2012","unstructured":"Simonen M, et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg. 2012;22(9):1473\u201380.","journal-title":"Obes Surg"},{"issue":"6","key":"6053_CR44","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/SLA.0000000000001552","volume":"264","author":"C Jahansouz","year":"2016","unstructured":"Jahansouz C, et al. Bile acids increase independently from hypocaloric restriction after bariatric surgery. Ann Surg. 2016;264(6):1022\u20138.","journal-title":"Ann Surg"},{"issue":"11","key":"6053_CR45","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1002\/oby.21658","volume":"24","author":"FH Khan","year":"2016","unstructured":"Khan FH, et al. Fibroblast growth factor 21 correlates with weight loss after vertical sleeve gastrectomy in adolescents. Obesity (Silver Spring). 2016;24(11):2377\u201383.","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"6053_CR46","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s11695-015-1878-1","volume":"26","author":"AP Belgaumkar","year":"2016","unstructured":"Belgaumkar AP, et al. Changes in bile acid profile after laparoscopic sleeve gastrectomy are associated with improvements in metabolic profile and fatty liver disease. Obes Surg. 2016;26(6):1195\u2013202.","journal-title":"Obes Surg"},{"key":"6053_CR47","doi-asserted-by":"publisher","first-page":"501739","DOI":"10.1155\/2009\/501739","volume":"2009","author":"T Li","year":"2009","unstructured":"Li T, Chiang JY. Regulation of bile acid and cholesterol metabolism by PPARs. PPAR Res. 2009;2009:501739.","journal-title":"PPAR Res"},{"key":"6053_CR48","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/bs.apha.2015.04.003","volume":"74","author":"T Li","year":"2015","unstructured":"Li T, Apte U. Bile acid metabolism and signaling in cholestasis, inflammation, and cancer. Adv Pharmacol. 2015;74:263\u2013302.","journal-title":"Adv Pharmacol"},{"issue":"4","key":"6053_CR49","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1210\/er.2000-0035","volume":"23","author":"JY Chiang","year":"2002","unstructured":"Chiang JY. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev. 2002;23(4):443\u201363.","journal-title":"Endocr Rev"},{"issue":"2","key":"6053_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","volume":"4","author":"JYL Chiang","year":"2020","unstructured":"Chiang JYL, Ferrell JM. Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis. Liver Res. 2020;4(2):47\u201363.","journal-title":"Liver Res"},{"issue":"1","key":"6053_CR51","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0006-291X(02)00229-2","volume":"293","author":"S Gupta","year":"2002","unstructured":"Gupta S, Pandak WM, Hylemon PB. LXR alpha is the dominant regulator of CYP7A1 transcription. Biochem Biophys Res Commun. 2002;293(1):338\u201343.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"6053_CR52","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0092-8674(00)81432-4","volume":"93","author":"DJ Peet","year":"1998","unstructured":"Peet DJ, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell. 1998;93(5):693\u2013704.","journal-title":"Cell"},{"issue":"4","key":"6053_CR53","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1128\/MCB.21.4.1393-1403.2001","volume":"21","author":"GP Hayhurst","year":"2001","unstructured":"Hayhurst GP, et al. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol. 2001;21(4):1393\u2013403.","journal-title":"Mol Cell Biol"},{"issue":"49","key":"6053_CR54","doi-asserted-by":"publisher","first-page":"41334","DOI":"10.1074\/jbc.M112.421834","volume":"287","author":"S Kir","year":"2012","unstructured":"Kir S, et al. Nuclear receptors HNF4alpha and LRH-1 cooperate in regulating Cyp7a1 in vivo. J Biol Chem. 2012;287(49):41334\u201341.","journal-title":"J Biol Chem"},{"issue":"3","key":"6053_CR55","doi-asserted-by":"publisher","first-page":"e0122273","DOI":"10.1371\/journal.pone.0122273","volume":"10","author":"HY Bhutta","year":"2015","unstructured":"Bhutta HY, et al. Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats. PLoS One. 2015;10(3):e0122273.","journal-title":"PLoS One"},{"issue":"5","key":"6053_CR56","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/ijo.2015.1","volume":"39","author":"R Dutia","year":"2015","unstructured":"Dutia R, et al. Temporal changes in bile acid levels and 12alpha-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes. Int J Obes (Lond). 2015;39(5):806\u201313.","journal-title":"Int J Obes (Lond)"},{"issue":"11","key":"6053_CR57","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1002\/oby.20890","volume":"22","author":"A Myronovych","year":"2014","unstructured":"Myronovych A, et al. The role of small heterodimer partner in nonalcoholic fatty liver disease improvement after sleeve gastrectomy in mice. Obesity (Silver Spring). 2014;22(11):2301\u201311.","journal-title":"Obesity (Silver Spring)"},{"key":"6053_CR58","doi-asserted-by":"publisher","first-page":"4390254","DOI":"10.1155\/2016\/4390254","volume":"2016","author":"OF Noel","year":"2016","unstructured":"Noel OF, et al. Bile acids, FXR, and metabolic effects of bariatric surgery. J Obes. 2016;2016:4390254.","journal-title":"J Obes"},{"issue":"3","key":"6053_CR59","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/hep.26427","volume":"58","author":"T Li","year":"2013","unstructured":"Li T, et al. Regulation of cholesterol and bile acid homeostasis by the cholesterol 7alpha-hydroxylase\/steroid response element-binding protein 2\/microRNA-33a axis in mice. Hepatology. 2013;58(3):1111\u201321.","journal-title":"Hepatology"},{"issue":"2","key":"6053_CR60","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/toxsci\/kfx191","volume":"160","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, et al. Editor\u2019s highlight: clofibrate decreases bile acids in livers of male mice by increasing biliary bile acid excretion in a PPARalpha-dependent manner. Toxicol Sci. 2017;160(2):351\u201360.","journal-title":"Toxicol Sci"},{"issue":"1","key":"6053_CR61","doi-asserted-by":"publisher","first-page":"9967","DOI":"10.1038\/s41598-017-10524-6","volume":"7","author":"Q Zhao","year":"2017","unstructured":"Zhao Q, et al. PPARalpha activation protects against cholestatic liver injury. Sci Rep. 2017;7(1):9967.","journal-title":"Sci Rep"},{"issue":"4","key":"6053_CR62","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s11605-021-04908-3","volume":"25","author":"GS Mazzini","year":"2021","unstructured":"Mazzini GS, et al. Gastric bypass increases circulating bile acids and activates hepatic farnesoid X receptor (FXR) but requires intact peroxisome proliferator activator receptor alpha (PPARalpha) signaling to significantly reduce liver fat content. J Gastrointest Surg. 2021;25(4):871\u20139.","journal-title":"J Gastrointest Surg"},{"issue":"12","key":"6053_CR63","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","volume":"48","author":"I Kim","year":"2007","unstructured":"Kim I, et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res. 2007;48(12):2664\u201372.","journal-title":"J Lipid Res"},{"doi-asserted-by":"crossref","unstructured":"Gottlieb A, Canbay A. Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression. Cells.\u00a02019;8(11):1358.","key":"6053_CR64","DOI":"10.3390\/cells8111358"},{"key":"6053_CR65","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fphys.2019.00374","volume":"10","author":"W Wang","year":"2019","unstructured":"Wang W, et al. Role of bile acids in bariatric surgery. Front Physiol. 2019;10:374.","journal-title":"Front Physiol"},{"issue":"5","key":"6053_CR66","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1210\/jc.2015-2583","volume":"101","author":"RA Haeusler","year":"2016","unstructured":"Haeusler RA, et al. Increased bile acid synthesis and impaired bile acid transport in human obesity. J Clin Endocrinol Metab. 2016;101(5):1935\u201344.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"6053_CR67","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00535-015-1148-y","volume":"51","author":"K Okushin","year":"2016","unstructured":"Okushin K, et al. The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease. J Gastroenterol. 2016;51(8):808\u201318.","journal-title":"J Gastroenterol"},{"issue":"21","key":"6053_CR68","doi-asserted-by":"publisher","first-page":"18793","DOI":"10.1074\/jbc.M109927200","volume":"277","author":"JJ Repa","year":"2002","unstructured":"Repa JJ, et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem. 2002;277(21):18793\u2013800.","journal-title":"J Biol Chem"},{"issue":"7","key":"6053_CR69","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1194\/jlr.M056978","volume":"56","author":"J Gu","year":"2015","unstructured":"Gu J, et al. Ethanol-induced hepatic steatosis is modulated by glycogen level in the liver. J Lipid Res. 2015;56(7):1329\u201339.","journal-title":"J Lipid Res"},{"issue":"3","key":"6053_CR70","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000470912","volume":"10","author":"S Mu","year":"2017","unstructured":"Mu S, et al. Roux-en-Y gastric bypass improves hepatic glucose metabolism involving down-regulation of protein tyrosine phosphatase 1B in obese rats. Obes Facts. 2017;10(3):191\u2013206.","journal-title":"Obes Facts"},{"issue":"11","key":"6053_CR71","first-page":"1142","volume":"15","author":"S Wu","year":"2012","unstructured":"Wu S, et al. Influence of gastric bypass surgery on hepatic gluconeogenesis in type 2 diabetic Goto Kakizaki rats. Zhonghua Wei Chang Wai Ke Za Zhi. 2012;15(11):1142\u20135.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"doi-asserted-by":"crossref","unstructured":"Li P, et al. Vertical sleeve gastrectomy improves liver and hypothalamic functions in obese mice. J Endocrinol. 2019;JOE-18-0658.R2.","key":"6053_CR72","DOI":"10.1530\/JOE-18-0658"},{"issue":"1","key":"6053_CR73","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1038\/s41467-021-24914-y","volume":"12","author":"N Bozadjieva-Kramer","year":"2021","unstructured":"Bozadjieva-Kramer N, et al. Intestinal-derived FGF15 protects against deleterious effects of vertical sleeve gastrectomy in mice. Nat Commun. 2021;12(1):4768.","journal-title":"Nat Commun"},{"issue":"6","key":"6053_CR74","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1053\/meta.2002.32732","volume":"51","author":"M Kusunoki","year":"2002","unstructured":"Kusunoki M, et al. Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886. Metabolism. 2002;51(6):792\u20135.","journal-title":"Metabolism"},{"issue":"8","key":"6053_CR75","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/sj.bjp.0702245","volume":"125","author":"R Upton","year":"1998","unstructured":"Upton R, et al. Improved metabolic status and insulin sensitivity in obese fatty (fa\/fa) Zucker rats and Zucker diabetic fatty (ZDF) rats treated with the thiazolidinedione, MCC-555. Br J Pharmacol. 1998;125(8):1708\u201314.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"6053_CR76","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/cld.31","volume":"1","author":"EM Brunt","year":"2012","unstructured":"Brunt EM. Histological assessment of nonalcoholic fatty liver disease in adults and children. Clin Liver Dis (Hoboken). 2012;1(4):108\u201311.","journal-title":"Clin Liver Dis (Hoboken)"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06053-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-022-06053-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06053-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T22:08:18Z","timestamp":1651788498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-022-06053-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6053"],"URL":"https:\/\/doi.org\/10.1007\/s11695-022-06053-5","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"type":"print","value":"0960-8923"},{"type":"electronic","value":"1708-0428"}],"subject":[],"published":{"date-parts":[[2022,4,14]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All applicable institutional and\/or national guidelines for the care and use of animals were followed and approved by NYU Long Island School of Medicine\u2019s Institutional Animal Use and Care Committee, which adheres to guidelines provided by the National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent does not apply.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Ankita Srivastava declares no conflict of interest; Matthew Stevenson declares no conflict of interest; Jenny Lee declares no conflict of interest; Christopher Hall declares no conflict of interest; Thomas Palaia declares no conflict of interest; Chaohui Lisa Zhao declares no conflict of interest; Raymond Lau declares no conflict of interest; Collin Brathwaite declares no conflict of interest; and Louis Ragolia declares no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Reversal of NAFLD After VSG is Independent of Weight-loss but RYGB Offers More Efficacy When Maintained On a High-Fat Diet @LouRags @mattRstevenson.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Twitter"}}]}}